Incyte Corporation Stock price

Equities

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-03-01 pm EST 5-day change 1st Jan Change
59.05 USD +1.18% Intraday chart for Incyte Corporation -2.54% -5.96%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 4.14B Sales 2025 * 4.61B Capitalization 13.26B
Net income 2024 * 838M Net income 2025 * 1.04B EV / Sales 2024 * 2.12 x
Net cash position 2024 * 4.47B Net cash position 2025 * 5.78B EV / Sales 2025 * 1.62 x
P/E ratio 2024 *
16.8 x
P/E ratio 2025 *
13.1 x
Employees 2,524
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.3%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.18%
1 week-2.54%
Current month+1.18%
1 month+1.20%
3 months+9.31%
6 months-8.72%
Current year-5.96%
More quotes
1 week
58.25
Extreme 58.25
61.48
1 month
56.10
Extreme 56.1
61.87
Current year
56.10
Extreme 56.1
67.37
1 year
50.27
Extreme 50.27
76.24
3 years
50.27
Extreme 50.27
88.26
5 years
50.27
Extreme 50.27
110.37
10 years
40.30
Extreme 40.3
153.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 14-01-12
Director of Finance/CFO 53 19-02-10
President 60 23-06-04
Members of the board TitleAgeSince
Director/Board Member 57 00-12-31
Director/Board Member 71 19-12-15
Director/Board Member 70 15-01-19
More insiders
Date Price Change Volume
24-03-01 59.05 +1.18% 1,574,698
24-02-29 58.36 -2.70% 3,086,977
24-02-28 59.98 -1.67% 1,118,697
24-02-27 61 +0.78% 1,370,002
24-02-26 60.53 -0.10% 1,246,939

Delayed Quote Nasdaq, March 01, 2024 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
59.05 USD
Average target price
75.82 USD
Spread / Average Target
+28.40%
Consensus
  1. Stock
  2. Equities
  3. Stock Incyte Corporation - Nasdaq
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW